Isis Vitravene
Executive Summary
FDA Dermatologic & Ophthalmic Drugs Advisory Committee will review fomivirsen for CMV retinitis treatment July 22, Isis says. The agency is giving the drug priority review. Isis filed the NDA April 9 ("The Pink Sheet" April 13, p. 29)...